RSS-Feed abonnieren
DOI: 10.1055/s-0044-1791973
Isolated Sixth Cranial Nerve Palsy in Patients with Pituitary Apoplexy
Funding None.
Abstract
Background Pituitary apoplexy is an acute clinical syndrome constituted by headache, visual impairment, ophthalmoplegia, and altered mental status. Abducens nerve palsy due to pituitary apoplexy is a significant clinical manifestation in pituitary apoplexy cases.This study aims to investigate the rare occurrence of isolated sixth cranial nerve palsy in patients with pituitary apoplexy, a condition characterized by sudden hemorrhagic or ischemic infarction of the pituitary gland.
Methods A search was conducted on major databases, including PubMed, Web of Science, and ScienceDirect, to identify cases of isolated sixth cranial nerve palsy in patients with pituitary apoplexy. Only six cases were found in the available literature. Descriptive statistics were used to summarize the data, and relevant clinical features were compared between the cases.
Results Among the six identified cases, isolated sixth cranial nerve palsy in patients with pituitary apoplexy predominantly affected middle-aged adults, with a prominent male preponderance. Clinical manifestations included acute-onset diplopia and headache, with the most common radiologic finding being pituitary gland enlargement or hemorrhage. Laboratory investigations revealed hormonal dysregulation in some cases. Treatment approaches varied and included conservative management and surgical intervention. Outcomes were generally favorable, with most patients experiencing partial or complete resolution of their cranial nerve palsy.
Conclusion Isolated sixth cranial nerve palsy in patients in the context of pituitary apoplexy is an exceptionally rare occurrence, with only six documented cases in the available literature. Further research and case reporting are essential to better understand this rare clinical entity and guide optimal management strategies.
Availability of Data and Material
Data are provided in the manuscript.
Authors' Contributions
O.A. was responsible for planning and collection of data and writing of the manuscript. A.B., W.A.A., and V.S. edited the manuscript. B.C. and R.K. were responsible for critical review and editing of the manuscript.
Ethical Approval
The study was performed in compliance with the ethical standards of the institutional research committee.
Publikationsverlauf
Eingereicht: 05. März 2024
Angenommen: 01. Juli 2024
Artikel online veröffentlicht:
08. November 2024
© 2024. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Barkhoudarian G, Kelly DF. Pituitary apoplexy. Neurosurg Clin N Am 2019; 30 (04) 457-463
- 2 Biagetti B, Simò R. Pituitary apoplexy: risk factors and underlying molecular mechanisms. Int J Mol Sci 2022; 23 (15) 8721
- 3 Rajasekaran S, Vanderpump M, Baldeweg S. et al. UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf) 2011; 74 (01) 9-20
- 4 Glezer A, Bronstein MD. Pituitary apoplexy: pathophysiology, diagnosis and management. Arch Endocrinol Metab 2015; 59 (03) 259-264
- 5 Muthukumar N. Pituitary apoplexy: a comprehensive review. Neurol India 2020; 68 (Supplement): S72-S78
- 6 Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CBT, Wass JAH. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf) 1999; 51 (02) 181-188
- 7 Verrees M, Arafah BM, Selman WR. Pituitary tumor apoplexy: characteristics, treatment, and outcomes. Neurosurg Focus 2004; 16 (04) E6
- 8 Zhu Q, Liang Y, Fan Z. et al. Ischemic infarction of pituitary apoplexy: a retrospective study of 46 cases from a single tertiary center. Front Neurosci 2021; 21: 808111
- 9 Varlamov EV, McCartney S, Fleseriu M. Functioning pituitary adenomas - current treatment options and emerging medical therapies. Eur Endocrinol 2019; 15 (01) 30-40
- 10 Kayayurt K, Gündogdu ÖL, Yavaşi Ö, Metin Y, Ugras E. Isolated abducens nerve palsy due to pituitary apoplexy after mild head trauma. Am J Emerg Med 2015; 33 (10) 1539.e3-1539.e4
- 11 Diyora B, Nayak N, Kukreja S, Kamble H. Sudden onset isolated complete third nerve palsy due to pituitary apoplexy. Oman J Ophthalmol 2011; 4 (01) 32-34
- 12 Gupta VK, Mamik HK, Gupta N, Bhagat RK. Pituitary apoplexy presenting as isolated unilateral third nerve palsy. Neurol India 2022; 70 (04) 1689-1691
- 13 Rosso M, Ramaswamy S, Sucharew H, Vagal A, Anziska Y, Levine SR. Isolated third cranial nerve palsy in pituitary apoplexy: case report and systematic review. J Stroke Cerebrovasc Dis 2021; 30 (09) 105969
- 14 Fadul A, Demir G, Safieh M. et al. Isolated sixth cranial nerve palsy as initial presentation of pituitary apoplexy: a case report. Cureus 2023; 15 (06) e41154
- 15 Matti AI, Rudkin AK, Lee AW, Chen CS. Isolated unilateral abducens cranial nerve palsy: a rare presentation of pituitary apoplexy. Eur J Ophthalmol 2010; 20 (01) 234-236
- 16 Singh A, Khurana M, Pal H, Azad S, Sihag RK, Kumar B. Bilateral sixth cranial nerve palsy, the first presenting feature of hemorrhagic apoplexy of pituitary macroadenoma: a case report. Int J Surg Case Rep 2022; 98: 107522
- 17 Syed SB, Mourra AA, Chatterjee T. Isolated unilateral abducens nerve palsy manifesting as a rare complication of idiopathic pituitary apoplexy: a case report. Cureus 2022; 14 (02) e22408
- 18 Warwar RE, Bhullar SS, Pelstring RJ, Fadell RJ. Sudden death from pituitary apoplexy in a patient presenting with an isolated sixth cranial nerve palsy. J Neuroophthalmol 2006; 26 (02) 95-97
- 19 Li M, Zhang J, Yang G. et al. Effects of anterior pituitary adenomas' hormones on glucose metabolism and its clinical implications. Diabetes Metab Syndr Obes 2023; 16: 409-424
- 20 Drummond JB, Ribeiro-Oliveira Jr A, Soares BS. Non-functioning pituitary adenomas. Rhinology and Anterior Skull Base Surgery: A Case-Based Approach. 2022: 161-168 Endotext [Internet]. Accessed July 3, 2024 at: https://www.ncbi.nlm.nih.gov/books/NBK534880/
- 21 Toda M, Kosugi K, Ozawa H, Ogawa K, Yoshida K. Surgical treatment of cavernous sinus lesion in patients with nonfunctioning pituitary adenomas via the endoscopic endonasal approach. J Neurol Surg B Skull Base 2018; 79 (Suppl. 04) S311-S315
- 22 Buchfelder M, Schlaffer SM. Surgical treatment of aggressive pituitary adenomas and pituitary carcinomas. Rev Endocr Metab Disord 2020; 21 (02) 253-261
- 23 Jane JA, Catalino MP, Laws ER. Surgical treatment of pituitary adenomas. Endotext [Internet]. 2022 . Accessed July 3, 2024 at: https://www.ncbi.nlm.nih.gov/books/NBK278983/
- 24 Esposito D, Olsson DS, Ragnarsson O, Buchfelder M, Skoglund T, Johannsson G. Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management. Pituitary 2019; 22 (04) 422-434